The adaptor protein SAP regulates type II NKT-cell development, cytokine production, and cytotoxicity against lymphoma

European Journal of Immunology

Volumn 44, Issue 12, 2014, Pages 3646-3657

  Weng, Xiufang ^a   Liao, Chia Min ^a   Bagchi, Sreya ^a   Cardell, Susanna L ^b   Stein, Paul L ^c   Wang, Chyung Ru ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c SRI INTERNATIONAL   (United States)

Author keywords

CD1d; Cytokines; NKT cell; SAP; T cell development

Indexed keywords

CD1D ANTIGEN; CD24 ANTIGEN; CYTOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERFERON REGULATORY FACTOR 4; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 4; L SELECTIN; RAG2 PROTEIN; SIGNALING LYMPHOCYTE ACTIVATION MOLECULE ASSOCIATED PROTEIN; TRANSCRIPTION FACTOR GATA 3; CD1D ANTIGEN, MOUSE; EARLY GROWTH RESPONSE FACTOR 2; EGR2 PROTEIN, MOUSE; GATA3 PROTEIN, MOUSE; KRUPPEL LIKE FACTOR; LYMPHOCYTE ANTIGEN RECEPTOR; SH2D1A PROTEIN, MOUSE; SIGNAL PEPTIDE; ZBTB16 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ARTICLE; CONJUGATION; CYTOKINE PRODUCTION; CYTOTOXICITY; HEMATOPOIETIC CELL; IMMUNE DYSREGULATION; LIVER; LYMPHOMA; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; SPLEEN; THYMUS; TRANSGENIC MOUSE; ANIMAL; CELLULAR IMMUNITY; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; PATHOLOGY; TUMOR CELL LINE; X CHROMOSOME LINKED DISORDER;

ANIMALS; ANTIGENS, CD1D; CELL LINE, TUMOR; EARLY GROWTH RESPONSE PROTEIN 2; GATA3 TRANSCRIPTION FACTOR; GENETIC DISEASES, X-LINKED; IMMUNITY, CELLULAR; INTERLEUKIN-4; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; LYMPHOMA; MICE; MICE, KNOCKOUT; NATURAL KILLER T-CELLS; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA;

EID: 84924322582     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201444848     Document Type: Article

References (51)

1. Rossjohn, J., Pellicci, D. G., Patel, O., Gapin, L. and Godfrey, D. I., Recognition of CD1d-restricted antigens by natural killer T cells. Nat. Rev. Immunol. 2012. 12: 845-857.
2. Juno, J. A., Keynan, Y. and Fowke, K. R., Invariant NKT cells: regulation and function during viral infection. PLoS Pathog. 2012. 8: e1002838.
3. Mattner, J., Natural killer T (NKT) cells in autoimmune hepatitis. Curr. Opin. Immunol. 2013. 25: 697-703.
4. Vivier, E., Ugolini, S., Blaise, D., Chabannon, C. and Brossay, L., Targeting natural killer cells and natural killer T cells in cancer. Nat. Rev. Immunol. 2012. 12: 239-252.
5. Halder, R. C., Aguilera, C., Maricic, I. and Kumar, V., Type II NKT cellmediated anergy induction in type I NKT cells prevents inflammatory liver disease. J. Clin. Invest. 2007. 117: 2302-2312.
6. Kadri, N., Korpos, E., Gupta, S., Briet, C., Lofbom, L., Yagita, H., Lehuen, A. et al., CD4(+) type II NKT cells mediate ICOS and programmed death-1-dependent regulation of type 1 diabetes. J. Immunol. 2012. 188: 3138-3149.
7. Renukaradhya, G. J., Khan, M. A., Vieira, M., Du, W., Gervay-Hague, J. and Brutkiewicz, R. R., Type I NKT cells protect (and type II NKT cells suppress) the host's innate antitumor immune response to a B-cell lymphoma. Blood 2008. 111: 5637-5645.
8. Baron, J. L., Gardiner, L., Nishimura, S., Shinkai, K., Locksley, R. and Ganem, D., Activation of a nonclassical NKT cell subset in a transgenic mouse model of hepatitis B virus infection. Immunity 2002. 16: 583-594.
9. Exley, M. A., He, Q., Cheng, O., Wang, R. J., Cheney, C. P., Balk, S. P. and Koziel, M. J., Cutting edge: compartmentalization of Th1-like noninvariant CD1d-reactive T cells in hepatitis C virus-infected liver. J. Immunol. 2002. 168: 1519-1523.
10. Liao, C. M., Zimmer, M. I., Shanmuganad, S., Yu, H. T., Cardell, S. L. and Wang, C. R., Dysregulation of CD1d-restricted type ii natural killer T cells leads to spontaneous development of colitis in mice. Gastroenterology 2012. 142: 326-334.
11. Zhao, J., Weng, X., Bagchi, S. and Wang, C. R., Polyclonal type II natural killer T cells require PLZF and SAP for their development and contribute to CpG-mediated antitumor response. Proc. Natl. Acad. Sci. USA 2014. 111: 2674-2679.
12. Das, R., Sant'Angelo, D. B. and Nichols, K. E., Transcriptional control of invariant NKT cell development. Immunol. Rev. 2010. 238: 195-215.
13. Kovalovsky, D., Uche, O. U., Eladad, S., Hobbs, R. M., Yi, W., Alonzo, E., Chua, K. et al., The BTB-zinc finger transcriptional regulator PLZF controls the development of invariant natural killer T cell effector functions. Nat. Immunol. 2008. 9: 1055-1064.
14. Savage, A. K., Constantinides, M. G., Han, J., Picard, D., Martin, E., Li, B., Lantz, O. et al., The transcription factor PLZF directs the effector program of the NKT cell lineage. Immunity 2008. 29: 391-403.
15. Seiler, M. P., Mathew, R., Liszewski, M. K., Spooner, C. J., Barr, K., Meng, F., Singh, H. et al., Elevated and sustained expression of the transcription factors Egr1 and Egr2 controls NKT lineage differentiation in response to TCR signaling. Nat. Immunol. 2012. 13: 264-271.
16. Lazarevic, V., Zullo, A. J., Schweitzer, M. N., Staton, T. L., Gallo, E. M., Crabtree, G. R. and Glimcher, L. H., The gene encoding early growth response 2, a target of the transcription factor NFAT, is required for the development and maturation of natural killer T cells. Nat. Immunol. 2009. 10: 306-313.
17. Matsuda, J. L., Zhang, Q., Ndonye, R., Richardson, S. K., Howell, A. R. and Gapin, L., T-bet concomitantly controls migration, survival, and effector functions during the development of Valpha14i NKT cells. Blood 2006. 107: 2797-2805.
18. Townsend, M. J., Weinmann, A. S., Matsuda, J. L., Salomon, R., Farnham, P. J., Biron, C. A., Gapin, L. et al., T-bet regulates the terminal maturation and homeostasis of NK and Valpha14i NKT cells. Immunity 2004. 20: 477-494.
19. Kim, P. J., Pai, S. Y., Brigl, M., Besra, G. S., Gumperz, J. and Ho, I. C., GATA-3 regulates the development and function of invariant NKT cells. J. Immunol. 2006. 177: 6650-6659.
20. Dose, M., Sleckman, B. P., Han, J., Bredemeyer, A. L., Bendelac, A. and Gounari, F., Intrathymic proliferation wave essential for Valpha14+ natural killer T cell development depends on c-Myc. Proc. Natl. Acad. Sci. USA 2009. 106: 8641-8646.
21. Mycko, M. P., Ferrero, I., Wilson, A., Jiang, W., Bianchi, T., Trumpp, A. and MacDonald, H. R., Selective requirement for c-Myc at an early stage of V(alpha)14i NKT cell development. J. Immunol. 2009. 182: 4641-4648.
22. Michel, M. L., Mendes-da-Cruz, D., Keller, A. C., Lochner, M., Schneider, E., Dy, M., Eberl, G. et al., Critical role of ROR-gammat in a new thymic pathway leading to IL-17-producing invariant NKT cell differentiation. Proc. Natl. Acad. Sci. USA 2008. 105: 19845-19850.
23. Hu, T., Simmons, A., Yuan, J., Bender, T. P. and Alberola-Ila, J., The transcription factor c-Myb primes CD4+CD8 +immature thymocytes for selection into the iNKT lineage. Nat. Immunol. 2010. 11: 435-441.
24. Choi, H. J., Geng, Y., Cho, H., Li, S., Giri, P. K., Felio, K. and Wang, C. R., Differential requirements for the Ets transcription factor Elf-1 in the development of NKT cells and NK cells. Blood 2011. 117: 1880-1887.
25. Egawa, T., Eberl, G., Taniuchi, I., Benlagha, K., Geissmann, F., Hennighausen, L., Bendelac, A. et al., Genetic evidence supporting selection of the Valpha14i NKT cell lineage from double-positive thymocyte precursors. Immunity 2005. 22: 705-716.
26. Nichols, K. E., Hom, J., Gong, S. Y., Ganguly, A., Ma, C. S., Cannons, J. L., Tangye, S. G. et al., Regulation of NKT cell development by SAP, the protein defective in XLP. Nat. Med. 2005. 11: 340-345.
27. Pasquier, B., Yin, L., Fondaneche, M. C., Relouzat, F., Bloch-Queyrat, C., Lambert, N., Fischer, A. et al., Defective NKT cell development in mice and humans lacking the adapter SAP, the X-linked lymphoproliferative syndrome gene product. J. Exp. Med. 2005. 201: 695-701.
28. Griewank, K., Borowski, C., Rietdijk, S., Wang, N., Julien, A., Wei, D. G., Mamchak, A. A. et al., Homotypic interactions mediated by Slamf1 and Slamf6 receptors control NKT cell lineage development. Immunity 2007. 27: 751-762.
29. Chan, B., Lanyi, A., Song, H. K., Griesbach, J., Simarro-Grande, M., Poy, F., Howie, D. et al., SAP couples Fyn to SLAM immune receptors. Nat. Cell Biol. 2003. 5: 155-160.
30. Cen, O., Ueda, A., Guzman, L., Jain, J., Bassiri, H., Nichols, K. E. and Stein, P. L., The adaptor molecule signaling lymphocytic activation moleculeassociated protein (SAP) regulates IFN-gamma and IL-4 production in V alpha 14 transgenicNKTcells via effects on GATA-3 and T-bet expression. J. Immunol. 2009. 182: 1370-1378.
31. Das, R., Bassiri, H., Guan, P., Wiener, S., Banerjee, P. P., Zhong, M. C., Veillette, A. et al., The adaptormolecule SAP plays essential roles during invariant NKT cell cytotoxicity and lytic synapse formation. Blood 2013. 121: 3386-3395.
32. Gumperz, J. E., Roy, C., Makowska, A., Lum, D., Sugita, M., Podrebarac, T., Koezuka, Y. et al., Murine CD1d-restricted T cell recognition of cellular lipids. Immunity 2000. 12: 211-221.
33. Jahng, A., Maricic, I., Aguilera, C., Cardell, S., Halder, R. C. and Kumar, V., Prevention of autoimmunity by targeting a distinct, noninvariant CD1dreactive T cell population reactive to sulfatide. J. Exp. Med. 2004. 199: 947-957.
34. Skold, M., Faizunnessa, N. N., Wang, C. R. and Cardell, S., CD1d-specific NK1.1(+) T cells with a transgenic variant TCR. J. Immunol. 2000. 165: 168-174.
35. Woronicz, J. D., Calnan, B., Ngo, V. and Winoto, A., Requirement for the orphan steroid receptor Nur77 in apoptosis of T-cell hybridomas. Nature 1994. 367: 277-281.
36. Proust, R., Bertoglio, J. and Gesbert, F., The adaptor protein SAP directly associates with CD3zeta chain and regulates T cell receptor signaling. PLoS One 2012. 7: e43200.
37. Sanzone, S., Zeyda, M., Saemann, M. D., Soncini, M., Holter, W., Fritsch, G., Knapp, W. et al., SLAM-associated protein deficiency causes imbalanced early signal transduction and blocks downstream activation in T cells from X-linked lymphoproliferative disease patients. J. Biol. Chem. 2003. 278: 29593-29599.
38. Constantinides, M. G. and Bendelac, A., Transcriptional regulation of the NKT cell lineage. Curr. Opin. Immunol. 2013. 25: 161-167.
39. Akbari, O., Stock, P., Meyer, E. H., Freeman, G. J., Sharpe, A. H., Umetsu, D. T. and DeKruyff, R. H., ICOS/ICOSL interaction is required for CD4+ invariant NKT cell function and homeostatic survival. J. Immunol. 2008. 180: 5448-5456.
40. Park, S. H., Weiss, A., Benlagha, K., Kyin, T., Teyton, L. and Bendelac, A., Themouse CD1d-restricted repertoire is dominated by a few autoreactive T cell receptor families. J. Exp. Med. 2001. 193: 893-904.
41. Dutta, M., Kraus, Z. J., Gomez-Rodriguez, J., Hwang, S. H., Cannons, J. L., Cheng, J., Lee, S. Y. et al., A role for Ly108 in the induction of promyelocytic zinc finger transcription factor in developing thymocytes. J. Immunol. 2013. 190: 2121-2128.
42. Lacorazza, H. D., Tucek-Szabo, C., Vasovic, L. V., Remus, K. and Nikolich-Zugich, J., Premature TCR alpha beta expression and signaling in early thymocytes impair thymocyte expansion and partially block their development. J. Immunol. 2001. 166: 3184-3193.
43. Lee, Y. J., Holzapfel, K. L., Zhu, J., Jameson, S. C. and Hogquist, K. A., Steady-state production of IL-4 modulates immunity in mouse strains and is determined by lineage diversity of iNKT cells. Nat. Immunol. 2013. 14: 1146-1154.
44. Bassiri, H., Das, R., Guan, P., Barrett, D. M., Brennan, P. J., Banerjee, P. P., Wiener, S. J. et al., iNKT cell cytotoxic responses control T-lymphoma growth in vitro and in vivo. Cancer Immunol. Res. 2014. 2: 59-69.
45. Nichols, K. E., Ma, C. S., Cannons, J. L., Schwartzberg, P. L. and Tangye, S. G., Molecular and cellular pathogenesis of X-linked lymphoproliferative disease. Immunol. Rev. 2005. 203: 180-199.
46. Exley, M. A., Tahir, S. M., Cheng, O., Shaulov, A., Joyce, R., Avigan, D., Sackstein, R. et al., A major fraction of human bone marrow lymphocytes are Th2-like CD1d-reactive T cells that can suppress mixed lymphocyte responses. J. Immunol. 2001. 167: 5531-5534.
47. Chen, Y. H., Chiu, N. M., Mandal, M., Wang, N. and Wang, C. R., Impaired NK1+ T cell development and early IL-4 production in CD1-deficient mice. Immunity 1997. 6: 459-467.
48. Chun, T., Page, M. J., Gapin, L., Matsuda, J. L., Xu, H., Nguyen, H., Kang, H. S. et al., CD1d-expressing dendritic cells but not thymic epithelial cells can mediate negative selection of NKT cells. J. Exp. Med. 2003. 197: 907-918.
49. Cannons, J. L., Yu, L. J., Hill, B., Mijares, L. A., Dombroski, D., Nichols, K. E., Antonellis, A. et al., SAP regulates T(H)2 differentiation and PKCtheta-mediated activation of NF-kappaB1. Immunity 2004. 21: 693-706.
50. Mohrs, M., Shinkai, K., Mohrs, K. and Locksley, R. M., Analysis of type 2. immunity in vivo with a bicistronic IL-4 reporter. Immunity 2001. 15: 303-311.
51. Li, S., Choi, H. J., Felio, K. and Wang, C. R., Autoreactive CD1b-restricted T cells: a new innate-like T-cell population that contributes to immunity against infection. Blood 2011. 118: 3870-3878.